DetectaChem/MD-Bio Introduce Assay for Monkeypox Detection

DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively by the U.S. Department of Defense, U.S. Homeland Security, law enforcement, first responders and public health agencies around the world, today announce the launch of their MD-Bio

...

Continue Reading

Monkeypox vaccinations expanded

The UK Health Security Agency has announced today it recommends offering the smallpox vaccine Imvanex, which is shown to be effective against monkeypox, to those considered to be at higher risk of exposure.

Anyone can contract monkeypox, but ...

Continue Reading

Top of the pox

A story that is hard to miss, and is being reported on globally, is that of the current Monkeypox outbreak.

Continue Reading

Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions

Chimerix, a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announces it has entered into a definitive agreement with Emergent BioSolutions Inc. (Emergent) to acquire its exclusive

...

Continue Reading

SIGA Receives FDA approval for IV Formulation of TPOXX

SIGA Technologies, Inc. (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous (IV) formulation of TPOXX for the treatment of smallpox. The IV formulation is an important

...

Continue Reading

Wearable Air Sampler Detects Personal Exposure to SARS-CoV-2

Originally published by Yale School of Health

Masks, physical distancing, good hygiene, and ventilation can help reduce the transmission of COVID-19 in public places. But even when these measures are taken, scientists have sometimes detected SARS-CoV-2, the virus that causes COVID-19,

...

Continue Reading

Execs accused of exporting bioweapon device to receive compensation

Originally published in Japan Today

Executives of a Japanese company indicted last year over illegal export of items capable of producing biological weapons will be compensated after the case against them was dropped, their lawyer said Thursday.

The Tokyo District Court awarded

...

Continue Reading

Heat Biologics Unveils RapidVax

Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today unveiled its new RapidVax® cellular vaccine platform at the 2021 World Antiviral Congress. RapidVax is designed as a

...

Continue Reading

Ministers need training in core decision making skills to deal with national emergencies Coronadiary author David Finlay adds to comments made by vaccine tsar Kate Bingham

David Finlay, whose new book Coronadiary identifies that the COVID response was hindered by a lack of training for Ministers in core decision making skills and a failure to react to previous warnings to improve skills within government, calls for Ministers to receive professional training

...

Continue Reading

Vials of Smallpox found in Pennsylvania facility

According to recent reports, frozen vials labelled Smallpox have been found in a facility in Pensylvannia. Various news sources are reporting that 15 vials were "incidentally discovered" by a lab worker a Merck facility, 5 are labelled smallpox and the rest labelled vaccinia. The lab

...

Continue Reading

DOD Awards Dynavax $22 Million for Plague Vaccine Clinical Trial

The U.S. Department of Defense (DOD) awarded Dynavax Technologies Corporation with an agreement worth approximately $22 million over two and a half years, to execute a clinical trial combining the DOD’s recombinant plague (rF1V) vaccine with its own CpG 1018® adjuvant. Under the agreement,

...

Continue Reading

Two more cases of novel Alaskapox virus reported

Following on from the detection In 2015 and 2020 of two novel orthopox cases in the Fairbanks area of Alaska, the Alaska Department of Health and Social Services has recently reported that two additional infections were detected in July and August, of this year. 

The

...

Continue Reading

Monkeypox in DRC. 600 cases in 6 weeks.

In the paste 6 weeks, the WHO has reported an additional 629 cases of Monkeypox in the Democratic Republic of Congo (DRC). There have also been six additional monkeypox fatalities reported. 

From the beginning of the year through to August 8th, 2,523 cases have been reported

...

Continue Reading

CDC Stands Up New Disease Forecasting Center

On August 18th the CDC announced a new center designed to advance the use of forecasting and outbreak analytics in public health decision making. Once established, the Center for Forecasting and Outbreak Analytics will bring together next-generation public health data, expert disease

...

Continue Reading

Heat Biologics Announces Formation of Biothreat Advisory Board

Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces it has commenced development of a new biosecurity/biodefense initiative. The Company also announces it has formed an advisory board

...

Continue Reading

First ever case of Marburg in Guinea confirmed

A recently queried case of Marburg virus in Guinea has now been confirmed. This is the first time the virus, a highly infectious disease that casuse hemorrhagic fever, had been detected in Guinea, and West Africa.

The patient sought treatment at a local clinic in Koundou, where a

...

Continue Reading

BARDA purchases NUZYRA to treat anthrax infections

As part of ongoing national preparedness efforts, BARDA has purchased and begun accepting delivery of the antibiotic NUZYRA (omadacycline) from Paratek Pharmaceuticals of Boston, Massachusetts, to treat infections caused by anthrax.

The contract with Paratek was BARDA’s first

...

Continue Reading

Our Current Sponsors